Capital Performance Advisors’s CRISPR Therapeutics CRSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-42
Closed -$1.97K 739
2024
Q3
$1.97K Buy
+42
New +$1.97K ﹤0.01% 1569